Impact of factor VIII deficiency on clotting factor utilization in the United States

1 January 1983

journal article
research article
Published by Springer Nature in La Ricerca in Clinica e in Laboratorio

Vol. 13 (1) , 33-41
https://doi.org/10.1007/bf02904743

Abstract

In a study of 1,551 hemophiliacs over a 4-year period of time, factor VIII utilization was assessed. It is clear that factor VIII usage is a function of severity of disease and therapeutic program. The average amount of factor VIII used per patient was 39.880U/year. Patients seiected for home care, use significantly more than those patients not on home care. As much as 101,000 U/year are used by a small number of patients on prophylaxis. These data can be used in predicting source plasma requirements for annual national use as well as costs.

Keywords

This publication has 1 reference indexed in Scilit:

The availability of plasma products and the care of hemophilia patients
Published by American Medical Association (AMA) ,1981